Skip to content14159 capital (GP), LLC — GENOMIC HEALTH INC insider: 232 transactions · InsiderLens14159 capital (GP), LLC
- 10% owner at IDERA PHARMACEUTICALS, INC. · on record since Mar 28, 2006
- 10% owner at INTRABIOTICS PHARMACEUTICALS INC /DE · on record since Feb 28, 2006
- 10% owner at VIROPHARMA INC · on record since Mar 1, 2006
- Director at SEATTLE GENETICS INC /WA · on record since Jun 29, 2006
- 10% owner at SEATTLE GENETICS INC /WA · on record since Jun 29, 2006
- 10% owner at TAPESTRY PHARMACEUTICALS, INC · on record since Apr 20, 2006
- Director at GENOMIC HEALTH INC · on record since Sep 11, 2006
- 10% owner at ALLOS THERAPEUTICS INC · on record since Nov 30, 2006
- 10% owner at AUXILIUM PHARMACEUTICALS INC · on record since Mar 11, 2010
- 10% owner at GENOMIC HEALTH INC · on record since Feb 21, 2007
- 10% owner at BIOCRYST PHARMACEUTICALS INC · on record since Aug 8, 2007
- 10% owner at ALTEON INC /DE · on record since Aug 3, 2007
- Director at INCYTE CORP · on record since Aug 3, 2007
- 10% owner at INCYTE CORP · on record since Dec 19, 2007
- 10% owner at AP PHARMA INC /DE/ · on record since Oct 28, 2009
- 10% owner at ADOLOR CORP · on record since Apr 28, 2010
- Director at INTRABIOTICS PHARMACEUTICALS INC /DE · on record since Apr 8, 2010
- Director at TRIMERIS INC · on record since Sep 30, 2010
- 10% owner at TRIMERIS INC · on record since Sep 30, 2010
- 10% owner at VAXGEN INC · on record since Jul 29, 2010
- 10% owner at PHARMACYCLICS INC · on record since Aug 24, 2011
- 10% owner at TRANZYME INC · on record since Mar 14, 2012
- 10% owner at XOMA LTD /DE/ · on record since Mar 8, 2012
Insider trading activity of 14159 capital (GP), LLC
- Transactions on record
- 232
- since Feb 14, 2005
- Open-market buys
- 180
- $6.1M
- Open-market sells
- 31
- $746.8K
- Companies traded
- 12
- last filing Mar 5, 2012
Figures computed from official regulatory filings — methodology.
Companies where 14159 capital (GP), LLC has traded
Track record of 14159 capital (GP), LLC
Statistical track record
Free- Open-market buys
- 200
- Last buy
- Mar 5, 2012
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of 14159 capital (GP), LLC
Co-insiders of 14159 capital (GP), LLC
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
3 tx · $9.2K · Nov 24, 2008
14159, L.P.BIOCRYST PHARMACEUTICALS INC +6
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Mar 5, 2012 | Buy | 1,845 | 30.07 USD | $55.5K | SEC |
| Mar 5, 2012 | Buy | 2,419 | 29.52 USD | $71.4K | SEC |
| Mar 5, 2012 | Buy | 405 | 29.47 USD | $11.9K | SEC |
| Mar 5, 2012 | Buy | 2,254 | 29.96 USD | $67.5K | SEC |
| Feb 3, 2012 | Buy | 23,172 | 17.00 USD | $393.9K | SEC |
| Jan 3, 2012 | Other | -186,272 | 4.25 USD | $791.7K | SEC |
| Dec 16, 2011 | Buy | 7,828 | 27.29 USD | $213.6K | SEC |
| Nov 30, 2011 | Buy | 1,815 | 14.26 USD | $25.9K | SEC |
| Nov 30, 2011 | Buy | 1,393 | 13.38 USD | $18.6K | SEC |
| Nov 30, 2011 | Buy | 2,568 | 14.12 USD | $36.3K | SEC |
| Nov 30, 2011 | Buy | 2,659 | 13.32 USD | $35.4K | SEC |
| Sep 8, 2011 | Buy | 1,075 | 17.06 USD | $18.3K | SEC |
| Sep 8, 2011 | Buy | 271 | 17.27 USD | $4.7K | SEC |
| Sep 8, 2011 | Buy | 427 | 17.00 USD | $7.3K | SEC |
| Aug 25, 2011 | Buy | 52 | 14.98 USD | $779 | SEC |
| Aug 25, 2011 | Buy | 7,228 | 15.53 USD | $112.3K | SEC |
| Aug 25, 2011 | Buy | 67 | 14.60 USD | $978.2 | SEC |
| Aug 25, 2011 | Buy | 135 | 15.35 USD | $2.1K | SEC |
| Aug 25, 2011 | Buy | 2,562 | 14.79 USD | $37.9K | SEC |
| Aug 25, 2011 | Buy | 95 | 14.98 USD | $1.4K | SEC |
| Aug 25, 2011 | Buy | 7,787 | 15.45 USD | $120.3K | SEC |
| Aug 24, 2011 | Buy | 3,339 | 9.97 USD | $33.3K | SEC |
| Aug 24, 2011 | Buy | 86 | 10.00 USD | $860 | SEC |
| Aug 24, 2011 | Buy | 1,001 | 9.93 USD | $9.9K | SEC |
| Aug 3, 2011 | Sell | -1,001 | 17.25 USD | $17.3K | SEC |